Helix BioPharma Corp. Provides Third Bi-Weekly MCTO Status U

RICHMOND HILL, ON / ACCESSWIRE / November 30, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and

Related Keywords

Canada , Toronto , Ontario , Richmond Hill , Canadian , Frank Michalargias , Toronto Stock Exchange , Helix Biopharma Corp , Ontario Securities Commission Under National , Helix Biopharma , Ontario Securities Commission , National Policy , Cease Trade Orders , Annual Filings , Target Filing , Chief Financial , Looking Statements , New Target Filing , Annual Information Form , Helix , Iopharma , Orp , Rovides , Third , Weekly , Cto , Status , Update ,